Hong Kong Journal of Nephrology
Volume 10, Issue 2 , Pages 74-77, October 2008

Coexisting Cutaneous Aspergillosis and Pulmonary Tuberculosis in a Renal Transplant Recipient

  • Chi Yuen Cheung

      Affiliations

    • Renal Unit, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR
    • Corresponding Author InformationCorrespondence to: Dr. Chi Yuen Cheung, Department of Medicine, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong SAR
    • ,
  • Tak Chiu Wu

      Affiliations

    • Infectious Diseases Unit, and Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR
    • ,
  • Yiu Han Chan

      Affiliations

    • Renal Unit, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR
    • ,
  • King Chung Lee

      Affiliations

    • Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR
    • ,
  • Hoi Wong Chan

      Affiliations

    • Renal Unit, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR
    • ,
  • Ka Foon Chau

      Affiliations

    • Renal Unit, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR
    • ,
  • Chun Sang Li

      Affiliations

    • Renal Unit, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR

Article Outline

We report a 70-year-old renal transplant recipient with endophthalmitis and cutaneous aspergillosis who presented with painful red eye and skin nodules. The presenting symptoms subsided gradually after voriconazole therapy. However, he developed fever with progressive pulmonary infiltrates. He was subsequently diagnosed to have coexisting pulmonary tuberculosis. This case illustrates that co-infection should always be borne in mind in immunocompromised patients, especially when the patient's clinical condition fails to respond favorably to initial treatment.

Key words:  aspergillosis , endophthalmitis , pulmonary tuberculosis , renal transplant

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Cornet M , Fleury L , Maslo C , Bernard JF , Brücker G , Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hôpitaux de Paris  . Epidemiology of invasive aspergillosis in France: a six-year multicenter survey in the Greater Paris area . J Hosp Infect . 2002;51:288–296
  2. Lin SJ , Schranz J , Teutsch SM . Aspergilllosis case-fatality rate: systemic review of the literature . CID . 2001;32:358–366
  3. Patterson TF , Kirkpatrick WR , White M , Hiemenz JW , Wingard JR , Dupont B , et al.   Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group . Medicine (Baltimore) . 2000;79:250–260
  4. Van Burik JA , Colven R , Spach DH . Cutaneous aspergillosis . J Clin Microbiol . 1998;36:3115–3121
  5. Ricci RM , Evans JS , Meffert JJ , Kaufman L , Sadkowski LC . Primary cutaneous Aspergillus ustus infection: second reported case . J Am Acad Dermatol . 1998;38:797–798
  6. Schelenz S , Goldsmith DJA . Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients . J Infect . 2003;47:336–343
  7. Riddell Iv J , McNeil SA , Johnson TM , Bradley SF , Kazanjian PH , Kauffman CA . Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature . Medicine (Baltimore) . 2002;81:311–320
  8. Rao NA , Hidayat AA . Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis . Am J Ophthalmol . 2001;132:244–251
  9. US Renal Transplant Mycophenolate Mofetil Study Group  . Mycophenolate mofetil in cadaveric renal transplantation . Am J Kidney Dis . 1999;34:296–303
  10. Husni RN , Gordon SM , Longworth DL , Arroliga A , Stillwell PC , Avery RK , et al.   Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients . Clin Infect Dis . 1998;26:753–755
  11. Schaffner A , Schaffner T . Glucocorticoid-induced impairment of macrophage antimicrobial activity: mechanisms and dependence on the state of activation . Rev Infect Dis . 1987;9:S620–S629
  12. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis . N Engl J Med . 2002;347:408–415
  13. Fisher JF , Taylor AT , Clark J , Rao R , Espinel-Ingroff A . Penetration of amphotericin B into the human eye . J Infect Dis . 1983;147:164
  14. Savani DV , Perfect JR , Cobo LM , Durack DT . Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis . Antimicrob Agents Chemother . 1987;31:6–10
  15. Zhou L , Glickman RD , Chen N , Sponsel WE , Graybill JR , Lam KW . Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry . J Chromatogr B Analyt Technol Biomed Life Sci . 2002;776:213–220

PII: S1561-5413(08)60025-3

doi:10.1016/S1561-5413(08)60025-3

Hong Kong Journal of Nephrology
Volume 10, Issue 2 , Pages 74-77, October 2008

Article Tools